Progress in transduction of cerebellar Purkinje cells in vivo using viral vectors

被引:27
作者
Hirai, Hirokazu [1 ,2 ,3 ]
机构
[1] Gunma Univ, Grad Sch Med, Dept Neurophysiol, Gunma 3718511, Japan
[2] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan
[3] Japan Sci & Technol Agcy, SORST, Saitama, Japan
关键词
Purkinje cell; viral vector; lentivirus; adeno-associated virus; gene therapy;
D O I
10.1007/s12311-008-0012-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Expression of a foreign gene in cerebellar Purkinje cells in vivo is a powerful method for exploring the pathophysiology of the cerebellum. Although using developmental engineering many gene-modified mice have been generated, this approach is time-consuming and requires a lot of effort for crossing different lines of mice, genotyping and maintenance of animals. If a gene of interest can be transferred to and efficiently expressed in Purkinje cells of developing and mature animals, it saves much time, effort and money. Recent advances in viral vectors have markedly contributed to selective and efficient gene transfer to Purkinje cells in vivo. There are two approaches for selective gene expression in Purkinje cells: one is to take advantage of the viral tropism for Purkinje cells, which includes the tropism of adeno-associated virus and the vesicular stomatitis virus glycoprotein (VSV-G)-pseudotyped lentivirus. Another method, which might be used in combination with the first one, is utilization of a Purkinje-cell-specific promoter. Focusing mainly on these points, recent progress in viral-vector-mediated transduction of Purkinje cells in vivo is reviewed.
引用
收藏
页码:273 / 278
页数:6
相关论文
共 31 条
[11]   CD38 is critical for social behaviour by regulating oxytocin secretion [J].
Jin, Duo ;
Liu, Hong-Xiang ;
Hirai, Hirokazu ;
Torashima, Takashi ;
Nagai, Taku ;
Lopatina, Olga ;
Shnayder, Natalia A. ;
Yamada, Kiyofumi ;
Noda, Mami ;
Seike, Toshihiro ;
Fujita, Kyota ;
Takasawa, Shin ;
Yokoyama, Shigeru ;
Koizumi, Keita ;
Shiraishi, Yoshitake ;
Tanaka, Shigenori ;
Hashii, Minako ;
Yoshihara, Toru ;
Higashida, Kazuhiro ;
Islam, Mohammad Saharul ;
Yamada, Nobuaki ;
Hayashi, Kenshi ;
Noguchi, Naoya ;
Kato, Ichiro ;
Okamoto, Hiroshi ;
Matsushima, Akihiro ;
Salmina, Alla ;
Munesue, Toshio ;
Shimizu, Nobuaki ;
Mochida, Sumiko ;
Asano, Masahide ;
Higashida, Haruhiro .
NATURE, 2007, 446 (7131) :41-45
[12]   In vivo transduction of cerebellar Purkinje cells using adeno-associated virus vectors [J].
Kaemmerer, WF ;
Reddy, RG ;
Warlick, CA ;
Hartung, SD ;
McIvor, RS ;
Low, WC .
MOLECULAR THERAPY, 2000, 2 (05) :446-457
[13]   Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors [J].
Klein, RL ;
Meyer, EM ;
Peel, AL ;
Zolotukhin, S ;
Meyers, C ;
Muzyczka, N ;
King, MA .
EXPERIMENTAL NEUROLOGY, 1998, 150 (02) :183-194
[14]   Glia-synapse interaction through Ca2+-permeable AMPA receptors in Bergmann glia [J].
Lino, M ;
Goto, K ;
Kakegawa, W ;
Okado, H ;
Sudo, M ;
Ishiuchi, S ;
Miwa, A ;
Takayasu, Y ;
Saito, I ;
Tsuzuki, K ;
Ozawa, S .
SCIENCE, 2001, 292 (5518) :926-929
[15]  
Mandel RJ, 1998, J NEUROSCI, V18, P4271
[16]   Gene transfer to the nervous system: Prospects for novel treatments directed at diseases of the aging nervous system [J].
Mata, M ;
Glorioso, JC ;
Fink, DJ .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2003, 58 (12) :1111-1118
[17]   Gene therapy for Parkinson's disease using recombinant adeno-associated viral vectors [J].
Muramatsu, S ;
Tsukada, H ;
Nakano, I ;
Ozawa, K .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (05) :663-671
[18]   Use of herpes virus amplicon vectors to study brain disorders [J].
Neve, RL ;
Neve, KA ;
Nestler, EJ ;
Carlezon, WA .
BIOTECHNIQUES, 2005, 39 (03) :381-391
[19]   Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats [J].
Paterna, JC ;
Feldon, J ;
Büeler, H .
JOURNAL OF VIROLOGY, 2004, 78 (13) :6808-6817
[20]   Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters [J].
Peel, AL ;
Zolotukhin, S ;
Schrimsher, GW ;
Muzyczka, N ;
Reier, PJ .
GENE THERAPY, 1997, 4 (01) :16-24